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Abstract
During development, the growth of the animal body is accompanied by a concomitant elongation of the peripheral nerves,
which requires the elongation of integrated nerve fibers and the axons projecting therein. Although this process is of
fundamental importance to almost all organisms of the animal kingdom, very little is known about the mechanisms
regulating this process. Here, we describe the identification and characterization of novel mutant alleles of GlcAT-P, the
Drosophila ortholog of the mammalian glucuronyltransferase b3gat1. GlcAT-P mutants reveal shorter larval peripheral nerves
and an elongated ventral nerve cord (VNC). We show that GlcAT-P is expressed in a subset of neurons in the central brain
hemispheres, in some motoneurons of the ventral nerve cord as well as in central and peripheral nerve glia. We
demonstrate that in GlcAT-P mutants the VNC is under tension of shorter peripheral nerves suggesting that the VNC
elongates as a consequence of tension imparted by retarded peripheral nerve growth during larval development. We also
provide evidence that for growth of peripheral nerve fibers GlcAT-P is critically required in hemocytes; however, glial cells
are also important in this process. The glial specific repo gene acts as a modifier of GlcAT-P and loss or reduction of repo
function in a GlcAT-P mutant background enhances VNC elongation. We propose a model in which hemocytes are required
for aspects of glial cell biology which in turn affects the elongation of peripheral nerves during larval development. Our data
also identifies GlcAT-P as a first candidate gene involved in growth of integrated peripheral nerves and therefore establishes
Drosophila as an amenable in-vivo model system to study this process at the cellular and molecular level in more detail.
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Introduction
During animal development and growth, the nervous system
needs to expand in conjunction with the general expansion of
the body. Crucial to this process is the extension of integrated
nerve fibers, which contain axons connecting motoneurons in
the central nervous system (CNS) to their peripheral targets,
muscles and sensory neurons in the peripheral nervous system
(PNS) connecting to their synaptic partners in the CNS. Neurite
outgrowth, via growth-cone mediated mechanisms and growth-
cone guidance, towards a target has been extensively studied
[ 1 , 2 ] .C u r r e n tm o d e l ss u g g e s tt h a td u r i n gd e v e l o p m e n ta x o n a l
elongation occurs by extension of the growth cone [3].
However, once the growth cone reaches its final target and is
fully connected and thus tightly integrated, growth-cone related
axonal elongation mechanisms are unlikely functional any
longer. Mechanical forces have been postulated to stimulate
elongation of integrated axons as the animal grows [4]. This
distinct process has been recently referred to as ‘‘stretch growth
of integrated axon tracts’’ [5]. Examples of such extreme axonal
stretch growth, where animal growth supplies constant me-
chanical tension on nerves and white matter tracts, are observed
throughout the animal kingdom [6,7]. As the anterior-posterior
body axis of an animal extends during growth, the distance
between most neuronal somata in the CNS and PNS and their
respective target cells increases dramatically, exerting tensile
forces on the axons within the nerves. These forces would
normally stimulate the addition of cytoskeletal elements,
axolemma and other building materials along the axon to
compensate for the mechanical strain. In vitro studies have
demonstrated that integrated axon tracts can undergo stretch
growth [5,8,9]. Several studies have been reported using
explanted neurons from various organisms to understand stretch
induced axonal elongation in cell culture in vitro
[10,11,12,13,14,15] (reviewed in [16]). However, elongation of
integrated axons is not understood at the molecular level
particularly at the stage of a developing organism in vivo, partly
due to the lack of mutants of genes involved in this process.
Drosophila offers an amenable model system to study the process
of stretch growth of integrated axons, due to the high growth rate
of its larval body during development as well as its compliance to
genetic analyses [17]. Importantly, extensive growth is observed
during the four days of larval development. During this phase,
motoneuron axons that established connectivity to their muscle
targets during embryogenesis have to elongate in parallel to the
expansion of the larval body. However, very little is known about
the cellular and molecular mechanisms controlling the extension of
integrated peripheral nerves/axons during Drosophila larval
development.
Post-translational modifications of proteins are known to be
involved in nervous system development [18]. In particular,
glycosylation of membrane-targeted and secreted proteins is an
PLoS ONE | www.plosone.org 1 November 2011 | Volume 6 | Issue 11 | e28106essential process (reviewed in [19]). Glycosyltransferases, which
transfer monosaccharide units to an acceptor molecule, are
responsible for the synthesis of carbohydrate moieties on proteins.
The carbohydrate epitope Human Natural Killer 1 (HNK-1),
found on several cell adhesion molecules such as the neural cell
adhesion molecule (NCAM; [20]), is spatially and temporally
regulated during development of the central and peripheral
nervous systems. HNK-1 is assumed to be involved in cell-cell
interactions such as cell adhesion [21], migration [22] and neurite
extension [23]. The HNK-1 epitope, comprising of a unique
trisaccharide structure, HSO3-3GlcAb1-3Galb1-4GlcNAc-, is
sequentially synthesized by the glucuronosyltransferase P
(GlcAT-P) or the glucuronosyltransferase S (GlcAT-S) and by a
specific sulphotransferase (HNK-1ST) [24,25,26,27,28]. The
HNK-1 carbohydrate is also crucial for maintaining proper neural
function [29]. GlcAT-P glucuronyltransferase activity is also
required for proteoglycan and glycoprotein biosynthesis [30,31].
Another class of proteins modified by GlcAT-P is extracellular
matrix (ECM) proteins and some ECM proteins are known to bear
the HNK-1 epitope [20]. In Drosophila, production and secretion of
several ECM molecules is an essential function of hemocytes [32].
Besides ECM deposition, hemocytes are also involved in the
clearance of apoptotic cells. Possibly due to the above mentioned
functions, hemocyte migration along their normal routes and
arrival at their correct target tissues is vital for development and
survival [32]. A single GlcAT-P ortholog is present in metazoan
genomes, including humans, although, three paralogs have been
characterized in almost all metazoans: GlcAT-P (also termed b-1,
3-glucuronyltransferase 1 (B3GAT1)), GlcAT-S and GlcAT-I [33].
GlcAT-P has been described as the predominant glycosyltransfer-
ase for HNK-1 epitope biosynthesis in the brain. Human GlcAT-P
(B3GAT1) has been implicated as a candidate gene for schizo-
phrenia-like psychosis [34] and b3gat1 knock-out mice have been
reported to have synaptic plasticity defects [35,36]. Furthermore,
GlcAT-P loss of function resulted in head morphogenesis defects in
Medaka [37]. These studies together demonstrate a crucial role for
GlcAT-P in nervous system development and/or function.
However, despite the existence of a fly ortholog, very little is
known about the role of GlcAT-P in the development and/or
function of the Drosophila nervous system.
Here, we describe the isolation and characterization of novel
alleles of the GlcAT-P gene which we termed brave (brv). brv
mutants are characterized by an elongated larval ventral nerve
cord (VNC). We demonstrate that VNC elongation in brv
mutants occurs during larval development and not during
embryogenesis. We show that GlcAT-P is expressed in a subset
of central and peripheral glia, and neurons in the larval CNS. We
provide evidence that in brv mutant larvae the peripheral nerves
are shorter as compared to wild-type and as a consequence, in
GlcAT-P mutants, the VNC is possibly under mechanical tension
and most likely responds by elongation along the anterior-
posterior axis. This suggests a function of GlcAT-P in the growth
of integrated peripheral nerves during larval development. We
further demonstrate that for growth of peripheral nerves GlcAT-
P is critically required in hemocytes. Finally, we identify the glial
specific gene repo as a genetic modifier of GlcAT-P as the VNC
elongation phenotype is dramatically enhanced if the repo gene
dose is reduced in a brv mutant background. Thus, we suggest
that GlcAT-P is a major component of the genetic network
required in hemocytes and glia for stretch growth of integrated
peripheral nerve fibers during Drosophila larval development. Our
work is the first to identify a gene linked to the growth of
peripheral nerves.
Results
Isolation and genetic characterization of four novel
GlcAT-P alleles
To identify novel genes involved in larval brain morphogenesis,
we carried out an EMS screen in the genetic background of DOPA-
decarboxylase-GAL4 (DDC-GAL4); UAS-GFP transgenic flies. In these
flies, the GFP reporter protein is localized in the cytoplasm of
DDC-expressing cells, which allows easy visualization of the first
(L1), second (L2) and third instar (L3) larval CNS [38]. Three
pupal lethal mutants were isolated from the screen showing a
dramatically 2–3 times extended larval ventral nerve cord (VNC)
as compared to the VNC of wild-type controls (Figure 1A, B). In
addition to the extension in the anterior-posterior axis, the mutant
VNCs also displayed a considerable reduction in circumference.
Moreover, the brain lobes in brv mutants were oval in shape (in the
anterior-posterior direction), unlike their round morphology in
wild-type. Genetically, these three mutations fell into one
complementation group, demonstrating that they were indepen-
dent alleles of the same gene, which we termed brave (brv).




By deletion mapping, we were able to assign a region on the
third chromosome spanning 10 potential candidate genes
(Figure 1C) to the brv mutants. By sequence analysis of both the
genomic DNA and the cDNAs from those 10 genes, we could
demonstrate that all three brv alleles were single point mutations in
the GlcAT-P gene. In brv
1, a G to A transition at the splice acceptor
site located immediately before the start of the 7
th exon resulted in
a 14 bp deletion in the transcript RNA sequence due to a cryptic
splicing site. As a result, a frame shift was introduced changing the
amino acid sequence of the following 160 residues, before ending
in a premature stop codon (see Figure 1D; Figure S1A, B). brv
2 was
found to be a G to A transition leading to a premature stop codon
at the 10
th amino acid of the 7
th exon of GlcAT-P (Figure S1C).
Finally, brv
3 was characterized as a T to A transversion in the 27
th
position of the last (8
th) exon resulting in a non-synonymous Leu to
Gln polymorphism (conserved non-polar to polar amino acid) in
this position (Figure S1D, E).
To demonstrate that the observed brv mutant phenotype reflects
a loss of GlcAT-P function and is not due to potential second
site mutations, we followed two approaches: firstly, using the
FRT containing transposons PBac{PB}CG14142
c00688 and
PBac{PB}
c01618, we generated a GlcAT-P null allele via flippase-
induced precise deletion [39,40]. Precise deletion of GlcAT-P
(henceforth referred to as Df(3L)GlcAT-P) was verified by PCR
analysis and sequencing (data not shown). In addition, either




3) of the GlcAT-P protein was demonstrated by
immunoblotting using an anti-GlcAT-P antibody (Figure 1E).
Df(3L)GlcAT-P homozygous larvae died during pupal stages and
showed an extended larval VNC phenotype which was indistin-
guishable from the other brv alleles. Moreover, Df(3L)GlcAT-P
failed to rescue the brv
1, brv
2 and brv
3 mutant alleles in




3 are functional null alleles. Secondly, a genomic construct
containing exons 3 to 8 of GlcAT-P (P[acman] genomic construct
CH322-82E19) rescued the larval brain defects and the pupal
lethality of all three brv mutant alleles (Figure 1D). The
dispensability of the upstream promoter region and the first two
untranslated exons of GlcAT-P was surprising, but agreed with
genetic evidence that a deficiency also lacking these elements
(Df(3L)BSC379) genetically complemented the brv mutations
(Figure 1D). This suggests that alternative functional promoters
are present just upstream of the third exon of GlcAT-P. Although
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escapers (,10%, n=200) for all alleles. The escapers almost
always showed developmental defects in the legs (,98%, n=100)
and some had rudimentary wings (,30%, n=100).
GlcAT-P is contributed maternally (see BDGP; http://www.
fruitfly.org/cgi-bin/ex/bquery.pl?qtype=report&find=CG6207
&searchfield=CG). To address the function of maternally
expressed GlcAT-P, we generated brv
1 germline clones using
the FLP-DFS technique [41]. We could not detect an abnormal
phenotype in the nervous system of embryos lacking both
maternal and zygotic GlcAT-P (data not shown; see below),
indicating that this gene is dispensable for embryonic nervous
system development.
GlcAT-P is a key enzyme for HNK-1 epitope biosynthesis in the
nervous system [42]. In mice, depletion of GlcAT-P results in an
almost complete loss of HNK-1 expression in the brain [35]. On
the contrary, Drosophila Df(3L)GlcAT-P larvae showed a similar
pattern of HNK-1 modified proteins on immunoblots of brain
lysates when compared to wild-type (Figure S2A). To test for
possible redundancy of GlcAT-P and GlcAT-S, an anti-GlcAT-S
antibody was used in immunoblots of protein extracts from
Df(3L)GlcAT-P larval brains. GlcAT-S-specific bands were clearly
detected (Figure S2A). Thus, functional redundancy of GlcAT-P
and GlcAT-S might explain the presence of HNK-1 in
Df(3L)GlcAT-P larva.
GlcAT-P is expressed in a subset of glia, VUM
motoneurons and mushroom body neurons
To study the expression pattern of GlcAT-P during larval
development, we raised an anti-GlcAT-P antibody. However, we
did not obtain specific signals in whole mount L3 larval brains
using standard immunohistochemistry. To evaluate the function-
ality of the antibody, we performed immunolabeling with wing
imaginal discs from transgenic larvae carrying dpp
blink-GAL4 and
UAS-GlcAT-P. A clear signal was detected along the anterior
posterior border of the wing disc (Figure S2B) which was in
accordance with the endogenous dpp
blink-GAL4 expression pattern.
Using an EYFP-tagged Golgi-specific protein (Sqh::EYFP-Golgi,
[43]), we detected the over-expressed GlcAT-P protein in the
Golgi apparatus (Figure S2C), where GlcAT-P is normally
localized [44]. These findings indicate that the antibody
specifically recognizes GlcAT-P protein in an over-expression
paradigm in the right cellular compartment. As an alternative
approach, we generated N-terminal as well as C-terminal EGFP-
tagged fusion constructs of GlcAT-P by recombineering [45], using
P[acman] genomic constructs containing the entire GlcAT-P locus
(see methods). However, neither could we detect any specific
EGFP signal in immunohistochemistry experiments, nor did the
fusion constructs rescue the brv mutants, indicating that the EGFP
tagging impairs GlcAT-P sub-cellular localization and/or func-
tion. We also attempted in situ hybridization experiments with
GlcAT-P probes in the larval brain. However, although the probe
was shown to work specifically when GlcAT-P was over-expressed
in wing discs (data not shown), any in situ signal above background
was not observed in the larval brain. Lastly, we made use of a
GAL4-containing transposon inserted at the GlcAT-P locus
(Figure 1D, henceforth referred to as GlcAT-P-GAL4). When used
to drive expression of the reporter genes UAS-nbgal or UAS-mCD8-
mCherry, GlcAT-P-GAL4 showed expression in the salivary gland
primordia, amnioserosa and gut during embryogenesis (Figure
S3A, B; data not shown), mirroring most aspects of the
endogenous in situ hybridization expression pattern (see BDGP;
http://www.fruitfly.org/cgi-bin/ex/bquery.pl?qtype=report&
find=CG6207&searchfield=CG). This indicates that GlcAT-P-
GAL4 recapitulates the endogenous expression pattern of
GlcAT-P. In the larva, reporter expression was detected in
the tracheal system which connects to the VNC (data not
shown). GlcAT-P-GAL4 drove reporter gene expression in the
n e r v o u ss y s t e mi ns e t so fn e u r o n sin the brain lobes (Figure 2A–
G), the VNC (Figure 2H–P) as well as in the peripheral nerves
emanating from the VNC (Figure 2Q–S). Reporter gene
expression was detected in a subset of glial cells in the brain and the
VNC. In addition, GAL4 was expressed in most, but not all, of the
peripheral nerve glia. Within the larval brain lobes, GAL4 was also
detected in mushroom body neurons (Figure 2D–G). In the VNC
GlcAT-P-GAL4 expression was also found in two VNC neurons per
neuromere (arrows in Figure 2M, N). Based on their location in
ventral positions of the ventral midline, their bifurcating axons
(arrowheads in Figure 2N) leaving the VNC through the peripheral
nerves (red arrows in Figure 2N) and the transcriptional activity of a
VUM-specific GAL4 line (807-GAL4, see Figure S5), these neurons
were characterized as ventral-unpaired-median (VUM)-motoneu-
rons [46,47].
In brv mutants the VNC is elongated during larval
development
To determine when the VNC elongation occurs developmen-
tally, we examined central nervous system development during
embryogenesis and larval stages in brv mutants in the background
of elav-mCD8-GFP transgenic flies [48]. During late embryogenesis
(stage 17), elongation of the VNC could not be detected in
maternal and zygotic brv mutants (Figure 3A–D). However, in brv
mutant L1 larvae, an abnormally extended VNC was readily
detectable (n=7; Figure 3E–H). As larval development progressed
to L2 (n=7; Figure 3I–L) and L3 (n=7; Figure 3M–P), the
elongation of the VNC became more pronounced. We thus
conclude that VNC elongation in brv mutants does not take place
during embryonic development, but starts during early larval
development and progresses through L2 and L3 larval stages.
To test if the sequence as well as the size of metameric units in
the L3 VNC were affected in brv mutants, we analyzed the
expression profile of the homeotic genes Antp, Ubx, abdA and abdB,
which have been described to label parasegments PS3–PS5, PS5–
PS6, PS7–PS12 and PS13–PS14, respectively [49]. Our results
showed that all the parasegments in the brv mutants were present
and in the correct sequence (Figure 4) suggesting that the homeotic
identity of the parasegments as well as their sequence was correctly
specified in the larval VNC of brv mutants. We checked the
intactness of the VNC in brv mutant larvae by analyzing anti-
Futsch/22C10, anti-BP102, anti-Fas2, anti-Elav and anti-Repo
Figure 1. brv mutations are novel alleles of Drosophila GlcAT-P. (A, B) Phase contrast pictures of wild-type (brv
+) and brv
1 mutant L3 larva brains
showing the elongation of the larval VNC in brv (B). Bar: 50 mm. (C) Graphical display of the deficiencies (Df) used in the complementation test in
which the chromosomal region was narrowed to 60 kb. (+), (-) indicate complementing and non-complementing Df, respectively. (D) Illustration of
the structure of the GlcAT-P locus flanked by the predicted genes CG14142 and CG6199. Arrows indicate the direction of transcription. Exons are
boxed and translated regions are represented by filled boxes. The gray box indicates an exon which is spliced into one but not the other isoform. The
positions in which the brv
1, brv
2 and brv





3 mutant L3 larvae were blotted with an anti-GlcAT-P antibody. Tub: a-tubulin loading control.
doi:10.1371/journal.pone.0028106.g001
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PLoS ONE | www.plosone.org 4 November 2011 | Volume 6 | Issue 11 | e28106Figure 2. Analysis of GlcAT-P expression as revealed by GlcAT-P-GAL4 driven reporter. GlcAT-P is expressed in the larval brain lobes (A–G),
the VNC (H–P) and peripheral nerves (Q–S) in the L3 larva brain. lacZ reporter expression in the brain lobes (red, A) colabeled with a-Repo (green, B).
(C) Merged frames showing that GlcAT-P is expressed in a subset of Repo-positive glial cells (yellow; arrows). lacZ reporter expression in the
mushroom bodies (red, D) colabeled with the neuronal marker Elav (green, E). Merged frame (F) showing co-staining of GlcAT-P and Elav in Kenyon
cells (yellow; arrows). (G) Membrane targeted reporter (UAS-mCD8-mCherry) reveals expression of GlcAT-P in Kenyon cell neurites. lacZ reporter
expression (H, K) in the larval VNC double labeled with a-Repo (I, J) or a-Elav (L, M). GlcAT-P is expressed in a subset of glial cells (yellow, arrows in J).
GlcAT-P expression is also found in about two Elav positive neurons in ventral midline positions (yellow, arrows in M). (N–P) UAS-mCD8-mCherry
reporter expression reveals that two cells (white arrow in N) bifurcate (arrowheads) and extend motor axons (blue arrows) bilaterally into the
periphery. (P). GlcAT-P.lacZ reporter expression (Q) in cells on peripheral nerves are shown. These cells are peripheral glia as they colabel with Repo
(R; yellow and arrows in S). A–F, H–J and K–M show individual frames of 1 mm thickness. G and N are maximum projections of Z-stacks. Bars in A, S:
50 mm. Bars in F, G: 10 mm.
doi:10.1371/journal.pone.0028106.g002
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expression pattern of these genes and we concluded that the
structural integrity of the VNC was not grossly affected in brv
mutants.
We also checked the integrity of mushroom body neurons and
VUM neurons in brv mutant larval brains by labeling them with
UAS-mCD8-GFP using GAL4-OK107 [50] and 807-GAL4 (A.
Brand, unpublished), respectively. The brv mutation did not affect
the viability of these neurons, but a displacement of their cell
bodies and neurites along the longitudinal axis was observed
(Figure S5) possibly as a consequence of the elongation of the
nervous system along the anterior-posterior axis.
Neuroblast proliferation is normal in brv mutants
To examine whether the extension of the VNC could be due to
additional cells, we studied neuroblast (NB) proliferation in brv
mutants. We firstly analyzed the number of proliferating cells in
thoracic and abdominal segments of brv mutant VNCs during L3
larvae by anti-Miranda staining. Miranda (Mira) labels dividing
NBs and ganglion mother cells (GMCs). We could not detect any
significant difference in the number of proliferating Mira positive
cells in brv mutant versus wild-type larval brains (n=6; Figure 5A–
C). We also analyzed neuroblast lineages in the larval VNC of L3
brv mutants using anti-Neurotactin (Nrt) immunohistochemistry.
In L3 larva, Nrt labels active NBs and their larval-specific
secondary neurons [51]. Extra Nrt positive cells indicative of extra
proliferation could not be detected in thoracic segments
(Figure 5D–F) or in abdominal segments (Figure 5G–I) of the
VNC. For example, in wild-type VNCs, only 3 NBs per
hemisegment are mitotically active during L3 stages producing
small lineages that contain 4 to 12 Nrt positive cells [52]. Both the
number of Nrt labeled NB lineages and the number of cells within
these lineages was comparable between wild-type and brv mutant
abdominal neuromeres (Figure 5G, H–I). However, as a
consequence of the VNC extension, the spacing between the
abdominal Nrt positive lineages was increased in brv mutant larvae
(Figure 5H, I). In the thoracic segments, the extension resulted in a
misplacement of NB lineages towards the midline of the VNC, a
domain reserved to the neuropile in wild-type brains. In summary,
we present evidence that the elongation of the VNC in brv mutant
larvae is not due to extra cell proliferation of larval NBs.
Peripheral nerves are shorter in brv mutant larvae
Since GlcAT-P-GAL4 reporter gene expression was found in the
peripheral nerves and in the VUM motoneurons whose axons
project through the peripheral nerves towards their peripheral
muscle targets (Figure 2K, N, Q), we investigated whether the
length of these peripheral nerve fibers was affected in brv mutant
larvae. Using Nervana2-GAL4 (Nrv2-GAL4); UAS-GFP transgenic
flies [53], we measured the length of the longest nerve fibers
emanating from the most posterior end of the VNC in brv mutants
and compared it to wild-type. A substantial difference in the length
of the peripheral nerves was already detectable during L1 stages
but not at stage 17 embryos (data not shown) and the difference
was more evident in L2 and L3 larva (Figure 6A–I). We found that
nerve fibers in brv mutants were considerably shorter (wild-type:
750+/- 36 mm; brv mutants: 508+/- 40 mm, n=7 for each)
(Figure 6C, F, I) at L3 stage. The data demonstrated that
consistently peripheral nerves were shorter by about one third in
brv as compared to wt. As a consequence of the nerve fibers being
shorter, they also contained less total peripheral glia as compared
to wild-type, although the spacing and the distribution of
peripheral nerve glia on a similar long stretch of the nerve fibers
did not seem to be affected (Figure S6).
Shorter peripheral nerves could either be causative for the
extension of the VNC or, alternatively, a consequence of the
Figure 3. The VNC in brv mutants elongates during larval development and can be rescued by ectopic GlcAT-P expression. An Elav-
mCD8-GFP background is used to visualize the outlines of the VNC. (A–C) Representative images of stage 17 embryos. (A) Wild-type (brv
+) and (B) brv
1
maternal and zygotic mutant. The progressive elongation of the VNC during larval development is shown in L1 (E–G), L2 (I–K) and L3 (M–O). Larval
brains from wild-type (E, I, M), brv
1 (F, J, N) and specimen over-expressing GlcAT-P (C, G, K, O) in brv
1 mutant background are shown. (D, H, L, P)
Quantification of the length of the VNC (n=7, for each stage) is presented (* refers to CH322-82E19 rescued specimen. Double-sided arrows indicate
the length of the VNC. L1, 2, 3 refers to larval stages 1, 2, and 3. Bars: 50 mm.
doi:10.1371/journal.pone.0028106.g003
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wandering L3 wild-type and brv mutant larvae were performed. In
wild-type larvae, the brain and VNC as well as the peripheral
nerves were rapidly stretched and relaxed as the larvae moved
(Figure 6J–N; see also [53]). However, stretching and compression
was more evident in brv mutant larvae, in which the VNC
contracted more strongly and developed ripples as the larvae
constricted (arrowheads in Figure 6O–S). This suggested that the
larval VNC was under higher tension in brv mutants. To further
investigate whether the VNC is indeed under tension of shorter
peripheral nerves, we made use of elav-mCD8-GFP transgenic flies
[48] and observed the VNC in real time in wild-type and brv
mutant L2 larvae. Larvae were cold-immobilized and a cut was
made at the posterior end. This cut severed the connections
between the most posterior peripheral nerve fibers and their
respective body wall contacts and as a consequence any tension of
the most posterior nerves on the VNC would be released. We
observed that after this cutting procedure the VNC immediately
retracted in brv mutants (n=10; Figure 7C, D), whereas there were
no detectable changes in wild-type larvae (n=10; Figure 7A, B).
VNC retraction could not be seen in brv mutant L3 larvae after an
identical procedure, possibly because during L3 larval stages the
VNC is too deformed to return to its original length. To further
resolve if VNC elongation is the cause or the consequence of
shorter peripheral nerves, we made use of the Tubby (Tb) mutant.
Tb larvae are considerably shorter along the anterior-posterior axis
than wild-type larvae [13]. Although the length of the Tb VNC was
comparable to wild-type (Figure 7G, I), peripheral nerves were
shorter in Tb larvae (Figure 7G,J). However, when we compared
VNC extension in brv
-/- and in brv
-/-;T b
-/+ mutant L3 larvae, we
found that in brv
-/-;T b
+/- mutants the VNC was also extended but
significantly lesser as compared to brv
-/- mutants alone (Figure 7E–
I). This experiment demonstrated that the extension of the VNC
in brv mutants correlates with the total length of the larva. Since
the peripheral nerves and the tracheal system are the only physical
connections between the larval body wall and the CNS, our results
suggested that in brv mutants the VNC expands as a consequence
of increased tension from shorter peripheral nerves or trachea
possibly due to some growth retardation of larval peripheral nerves
or trachea.
GlcAT-P function is required in hemocytes
To test for the cell specific requirement of GlcAT-P, rescue
experiments with ubiquitous (Act5C-GAL4) as well as cell specific
GAL4 drivers for the tracheal system (btl-GAL4), neuronal (Elav-
GAL4) and glial cells (gcm-GAL4 and repo-GAL4) were performed.
We were unable to rescue brv mutants with the btl-GAL4 tracheal
driver ruling out any involvement of the tracheal system at least in
the VNC extension phenotype. We also could not rescue brv
mutants with the pan-neuronal driver Elav-GAL4 demonstrating
that expression of GlcAT-P in neurons is not sufficient to rescue the
VNC extension phenotype. However, ubiquitous expression by
Act5C-GAL4 completely rescued the phenotype (Figure S7; n=50)
showing that the VNC extension in brv mutants is a specific
consequence of loss of GlcAT-P function. Furthermore, the
catalytically dead version of GlcAT-P (GlcAT-P
cd) driven by
Act5C-GAL4 failed to rescue demonstrating that impairment of
GlcAT-P catalytic activity is sufficient for the brv mutant
phenotype. GlcAT-P driven by the pan-glial and hemocyte driver
gcm-GAL4 fully rescued the extended VNC phenotype as well as
the pupal lethality (Figure S7; n=50). However, another pan-glial
driver, repo-GAL4, was not able to rescue the brv mutant phenotype
(Figure S7; n=50). Most importantly, the brv mutant phenotype
was completely rescued (Figure S7; n=50) when GlcAT-P was
driven by the hemocyte specific driver, crq-GAL4. The rescue
experiments identified a critical role for GlcAT-P in hemocytes.
repo is a genetic modifier of GlcAT-P
In an attempt to identify interactors with GlcAT-P, we tested a
possible genetic interaction with the glial specific repo gene. Our
first observation that repo and GlcAT-P interacted came from our
rescue experiments when we observed enhanced elongation of the
VNC in the presence of one chromosome carrying the lethal repo-
GAL4 (henceforth referred to as repo) insertion in the background of
brv
1-/- larvae (Figure S7). The length of the extended VNC in
brv
1-/-, repo
-/+ L3 larvae was 560.8+/- 44.8 mm as compared to
382.8+/- 54.8 mmi nbrv
1-/- mutant larvae (Figure 8A–C, E; n=7
for each). This difference was statistically significant (p,0.0001).
Correspondingly, the posterior-most peripheral nerves shortened
from 508.6+/- 40.7 mmi nL 3brv
1-/- mutant larvae to 283.3+/-
48.8 mmi nbrv
1-/-, repo
-/+ larvae (Figure 8A–C, F; n=7 for each).
The shortening of peripheral nerves is statistically significant
(p,0.0001). Furthermore, rare brv
1-/-, repo
-/- L2 escapers showed
an even more severe extension of the VNC as compared to brv
-/-
L2 larvae and a similar extension as brv
-/-, repo
-/+ L3 larvae
(Figure 8D, E). The increase in brv
1-/-, repo
-/- L2 larvae was also
significant (p,0.0001) compared to L2 brv
-/- larvae. It is worth
noting that the VNC of brv
1-/-, repo
-/- L2 larvae almost spanned
the entire length of the larva (Figure 8E; see also Figure 3L), a
situation similar to late embryos where the VNC extends to the
most posterior end of the embryo. Interestingly, the peripheral
Figure 4. Parasegmental identity and sequence of homeotic
gene expression domains are not altered in brv mutants. L3
larva brains from brv
+ (A–D) and brv
1 mutants (E–H) were immuno-
stained with anti-Antp (A, E), anti-Ubx (B, F), anti-AbdA (C, G), and anti-
AbdB (D, H). (I–L) Histograms comparing the average lengths of the
homeotic expression domains (I: Antp; J: Ubx; K: AbdA; L: AbdB) are
shown. Dashed lines indicate parasegmental (PS) boundaries. Bar:
20 mm.
doi:10.1371/journal.pone.0028106.g004
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growth of peripheral nerves came to an almost complete halt in
brv
1-/-, repo
-/- double mutants (Figure 8F). These results strongly
support the notion that hemocytes as well as glial cells are
synergistically required for the growth of integrated peripheral
nerves during larval development.
Taken together, our data demonstrate that VNC extension in
brv mutants may be a result of increased tension exerted on the
VNC as a consequence of impaired peripheral nerve extension/
growth. In this context, GlcAT-P plays a crucial role in hemocytes
which might control some aspect of glial cell biology implicated in
the growth of integrated peripheral nerves. Further studies are
required to address the exact molecular and cellular mechanisms
of GlcAT-P function in hemocytes and glia.
Discussion
In this study, we have identified and characterized novel alleles
of the glucuronyltransferase GlcAT-P, the Drosophila homolog of
human B3GAT1. The loss of GlcAT-P function causes an extension
of the VNC probably due to the inability of the peripheral nerve to
stretch/grow in tandem with the growth of the larval body. We
also showed that hemocytes are critically required for the
extension of peripheral nerves during larval development but glia
also plays an important role. Our findings suggest that GlcAT-P is
involved in growth of integrated peripheral nerves during
Drosophila larval growth.
GlcAT-P is expressed in the larval nervous system
Although we spent considerable effort to study GlcAT-P protein
localization in larval brains, we were unsuccessful in detecting any
relevant signal using an antibody raised against Drosophila GlcAT-P
in tissue whole mounts although the antibodies worked on western
blots and in an over/mis-expression paradigm. The fact that we
could not detect GlcAT-P expression in specimen could be
attributable to a low endogenous expression level of GlcAT-P or,
alternatively, to steric hindrance of the antigenic epitope(s) due to
the particular subcellular localization of the GlcAT-P protein or to
its interaction with other proteins. However, a GlcAT-P-GAL4 line
with an insertion into the GlcAT-P locus allowed us to study the
embryonic and larval expression pattern of GlcAT-P. GlcAT-P-
GAL4 driven LacZ reporter expression could not be detected in the
hemocytes or embryonic CNS. But LacZ expression was clearly
detected in a subset of neurons (Kenyon cells and VUM
Figure 5. Larval VNC extension is not a consequence of extra larval NB and GMC proliferation. (A–C) Comparison of progenitor cells
(neuroblasts and GMCs) in the Antp expressing domain (anti-Antp staining not shown) of (A) brv
+ and (B) brv
1 mutants using anti-Mira. (C)
Quantification of Mira positive cells in brv
+ and brv
1. (D–I) anti- Nrt staining in thoracic (D–F) and abdominal neuromeres (G–I) of L3 larva brains in brv
+
(D, G) and brv
1 mutants (E, F, H,I). A1–A9: abdominal neuromeres 1 to 9. Arrowheads in H point to the 3 Nrt positive NB lineages in A3. A–B and D–I
represent maximum projections of Z-stacks. Bar: 20 mm.
doi:10.1371/journal.pone.0028106.g005
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neither impaired the viability of these neurons nor resulted in
obvious developmental defects, apart from the longitudinal
displacement of their cell bodies and neurites due to VNC
elongation.
During Drosophila nervous system development, the VNC
undergoes a process of condensation at late embryonic stages
[54]. Recently, a mutation in the C1GalTA gene, which codes for a
core 1 galactosyltransferase, has been isolated and its phenotype
characterized as a defect in embryonic VNC condensation [55].
C1GalTA is one of the several C1GalTs genes involved in mucin-
type O-glycosylation in Drosophila [55]. Interestingly, the C1GalTA
mutant phenotype is almost indistinguishable from brv mutants
with regard to the larval VNC extension. However, we have not
detected embryonic VNC condensation defects in brv mutants. We
attribute this difference to the expression of C1GalTA, but not
GlcAT-P, in the embryonic CNS [55].
GlcAT-P controls the length of the VNC and the
peripheral nerves
We observed a reverse correlation between the length of
peripheral nerves and the extension of the VNC in brv mutants. It
has been reported that tension on nerves during growth might
stimulate the elongation of axons [5]. It is conceivable that if
tension on nerves generated by the growing larval body cannot be
counteracted by concomitant growth of the peripheral nerves, the
VNC would be forced to compensate such tension by stretching,
thus resulting in the VNC extension phenotype observed in brv
mutants. Such notion is supported by the retraction of the VNC in
brv mutant larvae after severing the very posterior segments. This
procedure liberates the attachment of the most posterior
peripheral nerves to the posterior segments of the larva and at
least partially releases the tension on the nerves and the VNC.
Thus, our data is consistent with the hypothesis that GlcAT-P plays
a role in peripheral nerve growth during Drosophila larval
development. Alternatively, GlcAT-P might be required in the
VNC during larval stages to keep the VNC compacted. However,
our finding that the VNC extension is significantly reduced in
brv
-/-,T b
+/- mutants as compared to brv
-/- mutants indicates that
the VNC is not undergoing an active extension in brv mutants and
that the elongation is clearly dependent on the total length of the
larval body. This observation suggests that GlcAT-P is not
required for VNC compaction since the VNC should have been
elongated to a similar extent in the Tb
+/- background if GlcAT-P
would function in VNC compaction. Nevertheless, it cannot be
completely ruled out that brv mutation causes enhanced VNC
elasticity due to changes in the ECM deposited into the VNC by
hemocytes and maybe glia. As a consequence of reduced VNC
rigidity and its extension, the peripheral nerves do not bear
significant strain and hence are not induced to grow. It is also
feasible that both a defect in peripheral nerve growth as well as in
the elasticity of the VNC contribute to the extension of the VNC.
However, even in the context of the alternative explanation it is
still obvious that the final consequence is that peripheral nerves in
brv mutants do not elongate as much as they would in the wild type
(wt). During larval growth the terminals of axons in the peripheral
nerves progressively move away from the nervous system
predominantly as a consequence of the extension of the larva
along the anterior-posterior body axis. During wt larvae growth
the length of the VNC does not elongate much whereas the
peripheral nerves increase quite dramatically in length. This
reveals a mechanism which promotes extension of integrated
peripheral axons during larval growth. In contrast, in brv mutants a
significant reduction of the length of peripheral nerves is observed
and we suggest that due to the reduced growth of peripheral
nerves the VNC compensates the resulting tension by elongating.
Figure 6. brv mutant larvae display shorter peripheral nerves. Representative pictures of L1, L2 and L3 larval brains from brv
+ (A, B, C) and
brv
1 mutants (D, E, F) expressing Nrv2-GAL4;UAS-GFP
(S65T) to visualize the peripheral nerves. White arrowheads indicate the most posterior projecting
and longest peripheral nerves used for these measurements. Histograms (G, H, I) compare the average lengths of the longest peripheral nerves
during L1 (G), L2 (H) and L3 (I) larva between wild-type and brv
1 mutants. The peripheral nerves are significantly shorter in brv
1 mutants (*: p,0.0001).
(J–S) Representative frames, taken from time-lapse recordings of wandering larva expressing Nrv2-GAL4; UAS-GFP
(S65T), display the VNC during one full
cycle of a larval contraction and expansion during locomotion. A brv
+ (J–N) and brv
1 larva (O–S) is shown. Ripples (arrowheads in P, Q), indicative for
relaxation from tension, were detected only in VNC of brv
1 mutants but not in brv
+ (J–N). Bar: 100 mm. A time line (in sec) is shown below panels J–S.
doi:10.1371/journal.pone.0028106.g006
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of peripheral nerves/axons either indirectly via regulating the
compaction of the VNC or by directly regulating the growth of
peripheral nerves and the axons therein.
It is worthwhile to note that most organisms with a nervous
system exhibit elongation of the anterior posterior body axis
during development which normally goes beyond the growth of
the nervous system along the same axis. The contacts between e.g.
centrally located motoneurons and their peripheral muscles are
generally established before such extensive growth phases. A
mechanism of ‘‘stretch growth of integrated axon tracts’’ [5] has
been postulated to allow peripheral nerves and the integrated
axons in these nerves to grow in order to compensate for possible
tension arising from the growth process of the organism on the
central nervous system. Although such stretch growth of integrated
axon tracts seems to be fundamental to all growing organisms,
almost nothing is known about the cellular and molecular
mechanisms driving this process. Our data suggests that GlcAT-
P is involved in this mechanism as in the absence of GlcAT-P
function peripheral nerve growth is severely retarded.
GlcAT-P may regulate growth of integrated nerves via
glia and hemocytes
We also have demonstrated that GlcAT-P function is important
in hemocytes since targeted expression of GlcAT-P in hemocytes
fully rescued the VNC extension as well as pupal lethality whereas
neither expression in neurons nor in glia could rescue. Hemocytes
are known as versatile cells involved in immune response as well as
in immune system unrelated developmental mechanisms [32].
Interestingly, hemocytes have been shown to be required for brain
morphogenesis particularly in the process of embryonic VNC
condensation [54]. The onset of VNC condensation coincides with
the deposition of Collagen IV by hemocytes and a lack of
hemocyte migration is associated with a severe reduction in ECM
components [54] demonstrating that one major function of
hemocytes is ECM deposition. This is further supported by
findings that hemocytes express several ECM components such as
Peroxidisan, dSPARC, and the proteoglycan MDP; also it has
been shown that hemocytes produce structural components of the
basement membrane such as laminin A and collagen IV [56,57].
GlcAT-P could have a role in modifying ECM components
produced in hemocytes by adding sugar residues to such proteins
which in turn might influence cells directly exposed to such
modified ECM.
We have also shown that partial or complete loss of repo function
in brv mutant background results in further and progressive
extension of the VNC depending on the repo gene dose. These
observations clearly reveal that although GlcAT-P function is
required in hemocytes, the phenotypic manifestation of VNC
extension in brv mutants also involves functional glial cells. repo
affects glia differentiation as well as maintenance of glial function
[58,59,60]. Our finding indicates that if the population of glial cells
is genetically weakened by reducing or removing Repo function in
a brv
-/- mutant background, the VNC extension phenotype is
enhanced. Strikingly, in specimen double mutant for brv and repo,
the extended VNC stretches along the entire body axis of the
larva. This is comparable to the VNC extension in late embryos
suggesting that in brv
-/-, repo
-/- double mutants, the growth of
peripheral nerves is almost completely abolished thus leading to
the extreme extension of the VNC during larval growth.
Furthermore, the genetic interaction between brv and repo
establishes an important role for glia in stretch growth of
peripheral nerves and/or VNC elasticity. Interestingly, the
peripheral nerves are covered by a thick layer of ECM [61]. As
such, the ECM might be an important provider of contextual
information for peripheral glia as well as neurites projecting
through the nerves.
Some peripheral glial cells also express GlcAT-P which might
suggest that glial cells are also involved in either generating their
own matrix environment or directly control neurite extension.
However, expression of GlcAT-P specifically in glial cells did not
rescue the brv mutant phenotype and as such GlcAT-P function in
glia is not critical for peripheral nerve growth. Thus, we
hypothesize that GlcAT-P has a role in regulating the elongation
of integrated nerves and peripheral axons during development via
hemocytes and glia possibly by glycosylating and depositing ECM
related proteins. GlcAT-P which is mainly expressed in the brain
in vertebrates [30] has been shown to be involved in the
biosynthesis of the HNK-1 epitope [26] on integral membrane
glycoproteins such as the neural cell adhesion molecule [62],
myelin-associated glycoprotein [63], L1 [62], transiently expressed
axonal glycoprotein-1 [64], P0 [65] and Ependymin [66]. In
Figure 7. In brv mutant larvae the VNC appears to be under
tension of peripheral nerves. Representative pictures of L2 larvae
from brv
+ (A, B) and brv
1 mutants (C, D) expressing Elav-mCD8-GFP
before (A, C) and after (B, D) dislodging the connections of the posterior
most peripheral nerves. Arrowhead in (D) points towards a kink that





1-/+ (G) and brv
1-/-, Tb
1-/+ mutant (H)
L3 larvae expressing Nrv2-GAL4;UAS-GFP
(S65T). The e\tension of the VNC
in brv
1-/-, Tb
1-/+ is reduced as compared to brv
1-/-. Histograms (I, J)
quantify the average lengths of VNCs and posterior-most peripheral
nerves. brv
1-/-,T b
1-/+ VNCs are significantly shorter as compared to brv
1-/-
mutants (*: p=0.0005). White arrowheads indicate the posterior tip of
the VNC. Bars: 100 mm.
doi:10.1371/journal.pone.0028106.g007
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bear the HNK-1 epitope [20], and in mice, the HNK-1 epitope is
selectively found on myelinating Schwann cells associated with
motor axons [19]. In GlcAT-P/b3gat1 knock-out mice, an almost
complete loss of the HNK-1 epitope in the brain is observed [35].
In our analysis the HNK-1 epitope was still detected in
immunoblots of brv mutant larval CNS, suggesting that in the
fly, GlcAT-P is not required or is redundant for the generation of
the HNK-1 epitope. Indeed, GlcAT-S has been shown to be
involved in HNK-1 epitope synthesis as well [24] and we have
demonstrated that GlcAT-S protein is present in the fly larval-
CNS. Therefore, in Drosophila at least a partial redundancy
between GlcAT-P and GlcAT-S might explain the overall presence
of the HNK-1 epitope. It is worth noting that despite the apparent
lack of changes in global levels of the HNK-1 epitope, the VNC
extension phenotype was still completely penetrant in brv mutant
larvae. Hence, the extended VNC phenotype in brv mutant larvae
could be independent of the HNK-1 epitope. This is also
supported by the similarity to the phenotype of C1GalTA which
might indicate that GlcAT-P, like C1GalTA, is also involved in
generation of glucuronylated core 1 O-glycans [67,68]. Alterna-
tively, our analysis of HNK-1 expression levels might have
overlooked a specific HNK-1 carrying protein responsible for the
VNC extension phenotype, and as such VNC extension could still
be a result of a specific, yet unknown, protein lacking the HNK-1
epitope as a consequence of the loss of GlcAT-P activity. All three
brv alleles identified in the EMS screen affected the C-terminal
catalytic domain of GlcAT-P and ectopic expression the GlcAT-
P
cd was not able to rescue brv mutants. We conclude that loss of
catalytic GlcAT-P activity is sufficient to result in a functional null
mutation and the catalytic activity of GlcAT-P is crucial for
peripheral nerve growth.
Interestingly, one of the currently identified GlcAT-P protein
targets in vertebrates is the HNK-1 epitope carrying ECM
glycoprotein tenascin-C [67]. Ten-C is found in glial cells and
potentially promotes or inhibits neurite outgrowth in a context
dependant manner [69,70]. Glial cells and neurons/axons are also
known to interact with each other [71] by glia supporting axonal
functions e.g., by neurotrophic and metabolic support [72] as well
as by providing the extracellular matrix context [69,70]. Based on
these reports and our own observations, we suggest a model in
which GlcAT-P is critical in hemocytes possibly to deposit specific
ECM on peripheral nerves. The ECM then in turn is critical to
peripheral glia for stretch growth of the peripheral nerves for
example by directly or indirectly being involved in the incorpo-
ration of new membrane material to growing axons thereby
facilitating stretch growth of integrated axons during larval
growth. It has been shown that ECM is more than a mere
structural support to cells and instead is involved in signaling on
the molecular level via ECM receptors such as integrins,
dystroglycans, membrane associated heparan sulphate proteogly-
cans (HSPGs), glycipicans and syndecans [73,74,75]. For example,
integrins are crucial components of cell adhesion and together
with other ECM receptors can signal to the cytoskeleton of cells
leading to cell shape changes, regulation of cell proliferation, cell
migration, apoptosis and differentiation. Furthermore, a clear link
between ECM and axonal growth and growth cone pathfinding
has been established [73]. In this context the ECM has been
shown to regulate actomyosin contractility, actin polymerization
and actin stabilization and therefore might impact on the
cytoskeleton of signaling receiving cells via Src, FAK, Rac1,
RhoA and Rock leading to modified growth cone pathfinding
[76,77]. Therefore, it is possible that in the context of the extended
ventral nerve cord and the shorter peripheral nerves in GlcAT-P




1-/- L3 (C) and repo
-/-, brv
1-/- L2 larvae.
The CNS is visualized either by Nrv2-GAL4;UAS-GFP
(S65T) (A, B) or by repo-GAL4;UAS-GFP
(S65T) (C–D). White arrowheads indicate the tip of the VNC. (E, F)
Histograms compare the average lengths of VNCs (E) and the most posterior peripheral nerves (F) for L3 as well as L2 larvae. repo
-/+, brv
1-/- VNCs are
significantly longer as compared to brv
1-/- mutants (*: p,0.0001). Bar: 100 mm.
doi:10.1371/journal.pone.0028106.g008
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hemocytes and glia might lead to profound changes in the ECM
to cell signaling resulting in the observed peripheral nerve growth
phenotype. It is conceivable that ECM related mechanisms
contributing to early growth cone pathfinding are also involved
in growth of axons after the growth cones reached their final target
sites. However, currently the precise molecular and cellular
mechanisms how GlcAT-P affects axonal extension of integrated
axons in Drosophila peripheral nerves are unknown and need
further investigations.
Alternatively, GlcAT-P could play a role in glial proliferation or
migration. This finds some support by the observation that at least
the peripheral nerves had less total glia although spacing and
distribution of glial cells along the nerves seemed to be
unperturbed. The limited reduced number of peripheral glia
could then hamper the extension of peripheral nerves and thus
limit the elongation of peripheral axons. However, we did not
observe a general reduction of glial cells in brv mutants making a
general role of GlcAT-P in glial proliferation relatively unlikely.
In summary, we have isolated novel alleles of the Drosophila
homolog of the mammalian glucuronyltransferase b3gat1, GlcAT-P.
Functional analysis suggests that GlcAT-P is required in
hemocytes for the growth of peripheral nerves during development
in which glial cells also play a major role. The postembryonic
growth of organisms requires the continuous elongation of
integrated peripheral nerves and axons to accommodate for the
extension of the body axes during development. To our
knowledge, GlcAT-P is the first gene with a possible link to nerve
stretch growth. We propose that the developing Drosophila larval
nervous system and the GlcAT-P mutants characterized here will
be helpful in deciphering the basic cellular and molecular
mechanisms of nerve stretch growth in the future. Currently, the
major challenge is the identification of potential GlcAT-P targets
either via biochemical or genetic screens and the characterization
of their functional involvement. Given the high degree of
functional conservation of molecular and biochemical pathways
between insects and vertebrates, performing further mechanistic
studies on GlcAT-P in Drosophila most likely will deliver new




w*; DDC-GAL4 [38] and w*; UAS-GFPS65T were meiotically
recombined on the third chromosome. For the EMS mutagenesis
screen w*; DDC-GAL4, UAS-GFPS65T males were fed with 25 mM
EMS according to standard procedures. Following this, they were
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female virgins were mated together to establish the stocks
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The following fly strains were also used: elav-mCD8-GFP [48],
FRT2A, UAS-mCD8-GFP, dpp
blink-GAL4 [78], Sqh::EYFP-
Golgi [43], UAS-nbgal, hs-Flp, P{GawB}ey
OK107, PBac{GAL4D,
EYFP}GlcAT-P
PL00294 (used at GlcAT-P-GAL4), PBac{PB}
CG14142
c00688, PBac{PB}
c01618, 807-GAL4 (A Brand, unpub-
lished) and Tb
1. Fly stocks without reference are described in
flybase. Unless otherwise specified, all the mutant analysis was
done in brv
1 mutant allele. GlcAT-P cDNA was amplified from
DGRC plasmid LD40245 by PCR using the oligos RP1
(AATTGCGGCCGCTTGGTTCGTCACAATTTTTTATA) and
RP2 (AATTGGTACCTTTTTTTTTTTTTTTTTTGGAAAA-
TG). Catalytically dead GlcAT-P was generated by mutating
Asp333 to Ala by PCR. For making respective UAS-GlcAT-P lines,
the PCR products were cloned into the NotI-KpnI cleaved
transformation vector pUAST-attB.
Mapping the EMS lesions
RNA was extracted from homozygous brv mutant larvae using
the RNAeasy kit (Qiagen). cDNAs derived from the 10 genes in
the mapped region were synthesized using standard protocols
(Invitrogen) and sequenced for all the three alleles.
Rescue constructs and EGFP tagging by recombineering
The following construct from P[acman] resource (see http://
flypush.imgen.bcm.tmc.edu/pacmanfly) was used for rescue
experiments: CH322-82E19 (contains GlcAT-P without the first
two exons). N or C terminus of GlcAT-P was tagged to EGFP in
CH322-82E19 and CH321-38B20 (contains entire GlcAT-P and
some other genes) BACs from P[acman] resource. We used
Addgene plasmids 19173 and 19178 for EGFP-tagging by
recombineering [45]. All germ line transformants were generated
by Bestgene Inc, CA.
Antibody generation
Polyclonal antibodies were generated against peptides C-
RTRYKNTNLEHIDRLLVRP and C-EGRNALISKNGREN-
PHSK for GlcAT-P and GlcAT-S respectively (Genzym
Antibodies).
Immunoblotting
Third instar larvae or their brains were used for extract
preparation. Protein extracts were resolved by SDS-PAGE.
Immunoblots were probed with anti-HNK-1 (1:1000), rabbit
anti-GlcAT-P (1:1000), rabbit anti-GlcAT-S (1:1000) and mouse
anti-a-tubulin (1:10000, Sigma) using PVDF membranes (Perkin
Elmer) and Supersignal-detection kit (Thermo Scientific).
Immunohistochemistry
The following primary antibodies were used: mouse anti-elav
(1:20, Developmental Studies Hybridoma Bank (DSHB)), mouse
anti-repo (1:5, DSHB), mouse anti-antp (1:20, DSHB), mouse anti-
AbdB (1:10, DSHB), mouse anti-Ubx (1:20, kindly provided by R
White), rat anti-AbdA (1:200, kindly provided by J Casanova),
mouse anti-HNK-1 (1:1000, kindly provided by S Oka), rabbit
anti-Mira (1:5000, kindly provided by F Matsuzaki). In addition,
secondary goat antibodies conjugated to Alexa488 (Molecular
Probes), Cy3 or Cy5 (Jackson Immuno Research Laboratories)
were applied. Images were acquired with an Upright Olympus
FV-1000 Confocal Imaging system using FV10-ASW software.
For releasing the connections of the posterior peripheral nerves
with the larval muscles, the appropriately staged wild-type and brv
mutant larvae carrying elav-mCD-GFP were first cold-immobilized.
An image was captured using Leica MZ16F stereomicroscope
before and after the posterior-most nerve connections were
separated by making a minute cut in the posterior part of the
larvae.
Supporting Information
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presented. The 14 bp long deletion in the brv
1 cDNA (boxed) is a
consequence of a G to A mutation in the splice acceptor (black
box) and the use of a cryptic alternative splice acceptor (red box).
A G to A mutation transforms a Trp codon (TGG) to a Stop
codon (TAG) (C, boxed) in brv
2. A T to A transversion changes the
conserved, non-polar, Leu residue (CTG) into the polar Gln
amino acid (CAG) (D, boxed) in brv
3. (E) Partial alignment of
several GlcAT-P orthologs shows that the brv
3 mutation affects an
evolutionarily conserved hydrophobic residue (boxed).
(TIF)
Figure S2 (A) Protein preparations from brv
+ and Df(3L)GlcAT-P
brains were blotted with anti-HNK-1 (HNK-1) and anti-GlcAT-S
(GlcAT-S) antibodies. (B–C) Misexpression of UAS-GlcAT-P in L3
larva wing imaginal discs with Dpp
blink-GAL4. (B) Ectopic
expression of GlcAT-P is detected by a-GlcAT-P immunohisto-
chemistry in the typical pattern of dpp expression domain. The
white box indicates the region shown in (C). (C) Co-labeling
(arrows) of a-GlcAT-P (red) with Sqh::EYFP-Golgi (green) reveals
that GlcAT-P protein is localized to the Golgi apparatus. Bars in B
and C are 100 mm and 20 mm respectively.
(TIF)
Figure S3 GlcAT-P-GAL4 driven expression of a reporter gene
(nuclear b-Gal) recapitulates aspects of endogenous GlcAT-P
expression during embryogenesis. (A, B) Note that reporter gene
expression mimics the described GlcAT-P in situ hybridization
expression pattern (see BDGP;http://www.fruitfly.org/cgi-bin/
ex/bquery.pl?qtype=report&find=CG6207&searchfield=CG).
LacZ expression was detected in the amnioserosa (A; arrows) of
stage 14 embryos, and in salivary glands (B; arrowheads) and
the gut (arrows) at stage 17. Bar: 100 mm.
(TIF)
Figure S4 The general structure the VNC is unaffected in brv
mutant larvae. Labeling of L3 larva brains from wild-type (brv
+)
and brv
1 with anti-22C10 (A, B), anti-BP102 (C, D), anti-Fas2 (E,
F), anti-Elav (G, H) and anti-Repo (I, J) shows apparently normal
VNC structure in brv mutants. Bar: 50 mm.
(TIF)
Figure S5 Mushroom body neurons and VUM motoneurons
are apparently normal in brv mutants. (A, B) OK107-GAL4.UAS-
mCD8-GFP did not display any apparent defects in mushroom
bodies in L3 brains. Arrowheads point to the MB neurons. (C, D)
807-GAL4.UAS-mCD8-GFP showed that VUM neurons were
present in brv
1 mutants (arrowheads). Two consecutive abdominal
neuromeres (dashed lines) are shown. A–D represent maximum
projections of Z-stacks. Bar: 20 mm.
(TIF)
Figure S6 Peripheral glia spacing and distribution is not affected
in brv mutant larvae. (A) Labeling of L3 larva brains from brv
+ and
brv
1 mutants with anti-Repo antibody shows a similar spacing
between glia in the peripheral nerves. (B) Nrv2-GAL4.GFP
expression in L3 larva brains from wild-type (brv
+) and brv
1
mutants. (C) Merged frames of anti-Repo (red) and Nrv2-
GAL4.GFP (green). (D) Histograms depicting the average number
of glial cells in comparable stretches of the most posterior
peripheral nerves of brv
+ and brv
1 (n=30 for each) larvae. Bar:
50 mm.
(TIF)
Figure S7 Rescue of brv mutants by expression of GlcAT-P using
UAS/GAL4 system. Quantification of the length of the L3 VNCs
(A) and peripheral nerves (B) in different rescue experiment
settings is provided (*: p,0.0001).
(TIF)
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